Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001599298-23-000101)

Filing Details

Accession Number:: 0001599298-23-000101
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-13 16:49:19
Reporting Period:: 2023-12-13

Accepted Time:: 2023-12-13 16:49:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1599298	Summit Therapeutics Inc.	SMMT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1849682	Ankur Dhingra	C/O Summit Therapeutics Inc. 2882 Sand Hill Road, Suite 106 Menlo Park CA 94025	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-12-13	700	$2.15	235,258	No	4	P	Indirect	By Dhingra Family Revocable Trust
Common Stock	Acquisiton	2023-12-13	19,700	$2.17	254,958	No	4	P	Indirect	By Dhingra Family Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Dhingra Family Revocable Trust
No	4	P	Indirect	By Dhingra Family Revocable Trust

Footnotes

The Reporting Person purchased these shares in a single transaction on the open market.
The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.